Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?

American Journal of Cardiology

Volumn 94, Issue 6, 2004, Pages 797-800

  Al Khatib, Sana M ^a   Shaw, Linda K ^a   Lee, Kerry L ^a   O'Connor, Christopher ^a   Califf, Robert M ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOFETILIDE; PROPAFENONE; SOTALOL; WARFARIN;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DATA BASE; DISEASE CONTROL; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART RATE; HEART RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; CHI-SQUARE DISTRIBUTION; DIGOXIN; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; WARFARIN;

EID: 4544366747     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.06.009     Document Type: Article

References (18)

1. The CAST Investigators Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction N Engl J Med 321 1989 406 412
2. D.S. Echt, P.R. Liebson, L.B. Mitchell, R.W. Peters, D. Obias-Manno, A.H. Barker, D. Arensberg, A. Baker, L. Friedman, H.L. Greene Mortality and morbidity in patients receiving encainide, flecainide or placebo The Cardiac Arrhythmia Suppression Trial N Engl J Med 324 1991 781 788
3. The CAST II Investigators Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction N Engl J Med 327 1992 227 233
4. L.K. Hine, N.M. Laird, P. Hewitt, T.C. Chalmers Meta-analysis of empirical long term antiarrhythmic therapy after myocardial infarction JAMA 262 1989 3037 3040
5. K.K. Teo, S. Yusuf, C.D. Furberg Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials JAMA 270 1993 1589 1595
6. S.N. Singh, R.D. Fletcher, S.G. Fisher, B.N. Singh, H.D. Lewis, P.C. Deedwania, B.M. Massie, C. Colling, D. Lazzeri Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia N Engl J Med 333 1995 77 82
7. C. Torp-Pedersen, M. Moller, P.E. Bloch-Thomsen, L. Kober, E. Sandoe, K. Egstrup, E. Agner, J. Carlsen, J. Videbaek, B Marchant Dofetilide in patients with congestive heart failure and left ventricular dysfunction N Engl J Med 341 1999 857 865
8. A.L. Waldo, A.J. Camm, H. de Ruyter, P.L. Friedman, D.J. MacNeil, J.F. Pauls, B. Pitt, C.M. Pratt, P.J. Schwartz, E.P. Veltri Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction The SWORD Investigators Lancet 348 1996 7 12
9. D.G. Wyse, A.L. Waldo, J.P. DiMarco, M.J. Domanski, Y. Rosenberg, E.B. Schron, J.C. Kellen, H.L. Greene, M.C. Mickel, J.E. Dalquist The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
10. I.C. Van Gelder, V.E. Hagens, H.A. Bosker, J.H. Kingma, O. Kamp, T. Kingma, S.A. Said, J.I. Darmanata, A.J. Timmermans, J.G Tijssen A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
11. S.H. Hohnloser, K. Kuck, J. Lilienthal for the PIAF Investigators Rhythm or rate control in atrial fibrillation Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomized trial Lancet 356 2000 1789 1794
12. J. Carlsson, S. Miketic, J. Windeler, A. Cuneo, S. Haun, S. Micus, S. Walter, U. Tebbe Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study J Am Coll Cardiol 41 2003 1690 1696
13. The AFFIRM Investigators Baseline characteristics of patients with atrial fibrillation: the AFFIRM study Am Heart J 143 2002 991 991001
14. C.A. Boyle, P. Decoufle National sources of vital status information extent of coverage and possible selectivity in reporting Am J Epidemiol 131 1990 160 168
15. D.O. Stram, H. Sather, L. Wang Analysis of time to death after transplantation when transplants are only given to patients in remission Biometrics 52 1996 1079 1086
16. The AF-CHF Trial Investigators Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) Trial Am Heart J 144 2002 597 607
17. G.C. Gronefeld, J. Lilienthal, K. Kuck, S.H. Hohnloser Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation: results from a prospective randomized study Eur Heart J 24 2003 1430 1436
18. V.E. Hagens, A.V. Ranchor, E.V. Sonderen, H.A. Bosker, O. Kamp, J.G. Tijssen, J.H. Kingma, H.J. Crijns, I.C. van Gelder Effect of rate or rhythm control on quality of life in persistent atrial fibrillation: results from the Rate Control Versus Electrical Cardioversion (RACE) Study J Am Coll Cardiol 43 2004 241 247